ERBB2 and cancer: While high CTL infiltration is commonly associated with good prognosis in cancer, we observed that high expression of LDHC in Her2-enriched and triple negative breast tumors reduced or negated the favorable association between CTL infiltration and overall survival, suggestive of T cell dysfunction that could negatively impact immunotherapy responses (Fig. 1B).